Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Kaicheng Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institutes of Biomedical Sciences, Fudan University, 130 Dong'an Road, Xuhui District, Shanghai 200032, China. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Non-Small-Cell Lung, Gene Expression Regulation, Neoplastic, Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
microRNAs (miRNAs) are short non-coding RNAs that have been increasingly recognized for their significant roles in the progression of cancer. Distinct miRNAs exhibit diverse functions attributed to variations in their sequences. As a result of possessing highly homologous seed sequences, these miRNAs target overlapping or similar gene sets, thus performing analogous roles. However, different from this sight, our study discovered that miR-135a-5p and miR-135b-5p, despite differing by only one nucleotide, exhibit distinct functional roles. Using non-small cell lung cancer (NSCLC) as a paradigm, our findings unveiled the downregulation of miR-135a-5p and upregulation of miR-135b-5p within NSCLC through TCGA database. Consequently, we further investigated their functional differences in A549 cells. Overexpression of miR-135b-5p enhanced the proliferation and migration capabilities of A549 cells, whereas miR-135a-5p transfection exhibited the opposite effect. We demonstrated that the activation of specific enhancers serves as a crucial mechanism underlying the disparate functions exerted by miR-135a-5p and miR-135b-5p in the context of NSCLC, consequently instigating a shift from inhibition to activation in NSCLC progression. Finally, we validated through animal experiments that miR-135b-5p promoted tumor progression, while miR-135a-5p exerted inhibitory effects on NSCLC development. This study offers a novel perspective for researchers to elucidate functional disparities exhibited by highly homologous miRNAs (miR-135a-5p and miR-135b-5p) in the context of NSCLC, along with the transition from inhibitory to progressive states in NSCLC. This study provides a solid foundation for future investigations into the functional roles of highly homologous miRNAs in pathological situation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institutes of Biomedical Sciences, Fudan University, 130 Dong'an Road, Xuhui District, Shanghai 200032, China.
- Department of Urology, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Xuhui District, Shanghai 200032, China.
- Shanghai Key Laboratory of Organ Transplantation, 180 Fenglin Road, Xuhui District, Shanghai 200032, China.
ORCID-Profile: Kaicheng Zhou, Wenqiang Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhou, K., Li, W., Chen, L., Chen, S., Liu, M., Yang, Z., Mao, Z., & Yu, W. (2024). Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae068
Vancouver
Zhou K, Li W, Chen L, Chen S, Liu M, Yang Z, et al. Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae068
BibTeX
@article{Zhou2024,
author = {Zhou, Kaicheng and Li, Wenxuan and Chen, Lu and Chen, Siyue and Liu, Mengxing and Yang, Zhicong and Mao, Zhanrui and Yu, Wenqiang},
title = {Highly homologous miR-135a and miR-135b converting non-small cell lung cancer from suppression to progression via enhancer switching},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae068}
}
EUVIMED